Listed

Biomea Fusion, Inc.

BMEANasdaqCIK 1840439HealthcareFiscal year ends Dec 31

Reports and events: 109 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Biomea Fusion, Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-1421:35 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-420684
2026-09-2220:01 ET8-K8.01 Other events0001193125-26-397870
2026-08-0520:09 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-335085
2026-08-0520:07 ET8-K9.01 Financial statements and exhibits0001193125-26-335073
2026-06-1111:11 ET8-K5.07 Shareholder vote results0001193125-26-266687
2026-05-1121:01 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-217074
2026-05-1120:58 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-217037
2026-04-2812:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-183710
2026-04-2720:08 ETDEF 14AProxy statementPeriod 2026-06-100001193125-26-182080
2026-03-2420:12 ET10-KAnnual reportPeriod 2025-12-310001193125-26-121825
2026-03-2420:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-121811
2026-02-2511:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-068375
2026-01-1421:02 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-012908
2025-11-0421:09 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-264679
2025-11-0421:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-25-264631
2025-10-2420:10 ETSCHEDULE 13D/AOwnership report, active investor, amended0000929638-25-003999
2025-10-1020:06 ETSCHEDULE 13D/AOwnership report, active investor, amended0000929638-25-003884
2025-10-0721:06 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-233614
2025-10-0620:15 ET8-K8.01 Other events0001193125-25-231903
2025-08-0520:10 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-103041
2025-08-0520:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-103023
2025-07-2411:13 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-25-163815
2025-07-2221:15 ETSCHEDULE 13D/AOwnership report, active investor, amended0000929638-25-002664
2025-06-2021:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-25-143747
2025-06-1821:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-142830
2025-06-1720:53 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-142126
2025-06-1320:01 ET8-K5.07 Shareholder vote results0001193125-25-140718
2025-05-0520:10 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-063543
2025-05-0520:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-063523
2025-04-2820:05 ETDEF 14AProxy statementPeriod 2025-06-110001193125-25-100455
2025-03-3120:23 ET10-KAnnual reportPeriod 2024-12-310000950170-25-047775
2025-03-3120:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-047755
2025-03-2720:35 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-065564
2025-02-2821:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-042468
2025-01-1521:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-007107
2024-12-2020:06 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-283008
2024-10-3110:07 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-248083
2024-10-2921:19 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-118366
2024-10-2921:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-118344
2024-09-2720:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-227940
2024-07-3120:14 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-088584
2024-07-3120:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-088581
2024-06-1221:08 ET8-K5.07 Shareholder vote results0001193125-24-160033
2024-06-0720:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-157310
2024-05-0220:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-052121
2024-05-0220:05 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-052082
2024-04-2620:01 ETDEF 14AProxy statementPeriod 2024-06-120001193125-24-117942
2024-04-0120:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-083352
2024-04-0120:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-039304
2024-03-2820:05 ET10-KAnnual reportPeriod 2023-12-310000950170-24-038026

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.